创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: What are the features of PDC high-throughput in vitro drug efficacy platform

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-29 14:12
  • Views:

(Summary description)With the rapid development of biotechnology, the field of drug discovery and development is ushering in unprecedented changes. With its unique technical advantages, InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform brings a brand-new breakthrough in the field of drug research and development. The platform utilizes advanced technological means to conduct rapid, efficient and accurate in vitro drug efficacy assessment, which greatly improves the efficiency and success rate of drug R&D and injects new vitality into the development of the pharmaceutical industry.

InnoModels Biotechnology: What are the features of PDC high-throughput in vitro drug efficacy platform

(Summary description)With the rapid development of biotechnology, the field of drug discovery and development is ushering in unprecedented changes. With its unique technical advantages, InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform brings a brand-new breakthrough in the field of drug research and development. The platform utilizes advanced technological means to conduct rapid, efficient and accurate in vitro drug efficacy assessment, which greatly improves the efficiency and success rate of drug R&D and injects new vitality into the development of the pharmaceutical industry.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-29 14:12
  • Views:
Information

With the rapid development of biotechnology, the field of drug discovery and development is ushering in unprecedented changes. With its unique technical advantages, InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform brings a brand-new breakthrough in the field of drug research and development. The platform utilizes advanced technological means to conduct rapid, efficient and accurate in vitro drug efficacy assessment, which greatly improves the efficiency and success rate of drug R&D and injects new vitality into the development of the pharmaceutical industry.
1、Highly consistent primary cells
InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform uses the digestion products of PDX model to obtain highly consistent primary cells with patients. Such cells have complex cell subpopulations and biological characteristics, which can realistically simulate the drug response environment in the human body, making the drug's action and response closer to the clinical situation. At the same time, highly consistent primary cells provide more reliable experimental data for drug development and help researchers more accurately assess the efficacy and safety of drugs.
2. Pharmacodynamic response and clinical relevance
InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform is not only applicable to the screening of test drugs and models, but also capable of predicting the clinical efficacy of drugs. By comparing the subject drug with counterpart drugs (e.g., drugs with similar mechanism of action or standardized therapeutic drugs), the platform can predict the clinical value of the drug and provide powerful decision support for drug development. In addition, the platform can also compare the effective rates of different cancer type models through multi-dimensional applications, determine the indications of drugs, and search for biomarkers predicting drug efficacy through the differences in genetic characteristics between sensitive and resistant models, providing an important basis for personalized treatment.

 


3、Multi-parameter assay and multi-cell type support
The PDC high-throughput in vitro drug efficacy platform adopts advanced PDC technology, allowing researchers to simultaneously assess multiple cell phenotypic parameters, such as cell proliferation, cell cycle, apoptosis, etc., to provide a more comprehensive understanding of drug effects. In addition, the platform supports the application of multiple cell types, including tumor cells, primary cells, etc., which is suitable for drug research in different disease areas. This multi-parameter determination and multi-cell type support makes the drug development process more accurate and comprehensive, providing researchers with more dimensional research data.
4、High throughput screening and high efficiency
InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform is able to screen a large number of drugs in a short period of time, which improves the research efficiency. Compared with the traditional in vivo experimental platform, the experimental cycle of the in vitro experimental platform can be shortened by more than three times, and at the same time, the flux of the tested drugs can be increased by more than five times, while the cost is only a fraction of the in vivo experiments. This high-throughput screening feature makes the drug development process more efficient and rapid, saving a lot of time and money for researchers and accelerating the drug development process.
In conclusion, InnoModels' PDC high-throughput in vitro drug discovery platform brings a brand new breakthrough in the field of drug discovery and development with its high consistency of primary cells, clinical relevance of drug discovery, multi-parameter assay and multi-cell type support, as well as high-throughput screening and high efficiency. The platform provides researchers with a more accurate, comprehensive and efficient drug discovery and development tool, which helps to promote the rapid development of the pharmaceutical industry and make important contributions to human health.

Keyword:

In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司